Feature Channels: Personalized Medicine

Filters close
Released: 8-Aug-2022 4:05 PM EDT
暴露组探索:妙佑医疗国际(Mayo Clinic) 有关环境暴露对健康影响的研究
Mayo Clinic

来自空气、食物、产品和水中的环境化学物质、污染物、微生物和微粒可能会蓄积在我们每个人的体内。这些有时有害的暴露物会与我们的基因发生相互作用,从而引发疾病。妙佑医疗国际个体化医学中心的研究人员正在研究终生环境暴露(称为暴露组),并评估对这些暴露产生的生物反应。

Released: 8-Aug-2022 4:05 PM EDT
مايو كلينك تلقي الضوء على آثار التعرّض لمختلف العوامل البيئية على صحّة الإنسان
Mayo Clinic

تحتوي أجسادنا على تراكمات سنوات طويلة من المواد الكيميائية والملوّثات والميكروبات والجسيمات المتواجدة في البيئة المحيطة به، والتي نتعرّض لها يومياً عبر الهواء الذي نتنشّقه والطعام الذي نتناوله والمنتجات التي نلمسها والماء الذي نشربه.

Released: 8-Aug-2022 3:05 PM EDT
Exploración del exposoma: Mayo Clinic estudia el impacto de la exposición ambiental sobre la salud
Mayo Clinic

Dentro de cada uno de nosotros puede existir una acumulación de sustancias químicas y contaminantes del ambiente, de microbios y de partículas adquiridas del aire que respiramos, de los alimentos que comemos, de los productos que tocamos y del agua que bebemos.

Released: 4-Aug-2022 3:30 PM EDT
Genetic findings offer opportunity for personalized heart failure treatment
Brigham and Women’s Hospital

Heart failure is a common and devastating disorder for which there is no cure. Many cardiomyopathies —conditions that make it difficult for the heart to pump blood such as dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM) — can lead to heart failure, but treatments for patients with heart failure do not take these distinct conditions into account.

Newswise: CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Released: 4-Aug-2022 10:15 AM EDT
CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Children's Hospital of Philadelphia

Children’s Hospital of Philadelphia (CHOP) has helped launch a new computational platform that will harmonize pediatric cancer data, allowing researchers, pharmaceutical companies, and advocacy groups to accelerate the pace of drug development for pediatric cancer. With funding from the National Cancer Institute (NCI) via a subcontract with Leidos Biomedical Research, current operator of the NCI’s Frederick National Laboratory for Cancer Research, CHOP researchers have created the Molecular Targets Platform to facilitate pediatric research in response to the Research to Accelerate Cures and Equity (RACE) for Children Act, which requires companies to test cancer drugs in children that are used in adults when there is a shared molecular target.

Released: 1-Aug-2022 5:05 PM EDT
What to Look For in a Physical Therapy Facility
Hospital for Special Surgery

After an injury or surgery, physical therapy often plays an essential role in recovery. It can also improve fitness and function for people dealing with chronic pain. Experts from Hospital for Special Surgery offer tips on what to look for in a PT facility.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Newswise: Increased Precision and Safety in Spinal Tap with PASS – An Ultrasound-Guided Lumbar Puncture Procedure
Released: 29-Jul-2022 8:55 AM EDT
Increased Precision and Safety in Spinal Tap with PASS – An Ultrasound-Guided Lumbar Puncture Procedure
Chulalongkorn University

PASS (Point-Assisted Spinal Sonography), an ultrasound-guided lumbar puncture device from Chula doctors and engineers, helps increase the precision and confidence in spinal tap procedures while reducing risks and pain for patients.

19-Jul-2022 2:05 PM EDT
ACP Offers Guidance on the Ethical Use of Genetic Testing and Precision Medicine
American College of Physicians (ACP)

A new position paper from the American College of Physicians (ACP) offers guidance regarding ethical decision-making for the integration of precision medicine and genetic testing into internal medicine. ACP's advice is published in Annals of Internal Medicine.

Newswise: Major Expansion Announced for Vanderbilt University Hospital
Released: 25-Jul-2022 10:25 AM EDT
Major Expansion Announced for Vanderbilt University Hospital
Vanderbilt University Medical Center

Leaders with Vanderbilt University Medical Center announced plans today for construction of the largest expansion to date for Vanderbilt University Hospital (VUH). Through this project a new inpatient tower will be built atop an existing parking structure located between 21st Avenue South and Medical Center Drive.

20-Jul-2022 12:00 PM EDT
Artificial Intelligence in Personalized Medicine, Genomic Sequencing Advances, Human Brain Organogenesis, Building Trust with Patients, Guiding Patient Decisions with Mass Spectrometry, and Much More to Be Explored at 2022 AACC
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.

   
Newswise: Engineers Develop New Tool That Will Allow for More Personalized Cell Therapies
Released: 20-Jul-2022 10:00 AM EDT
Engineers Develop New Tool That Will Allow for More Personalized Cell Therapies
University of Minnesota College of Science and Engineering

A University of Minnesota Twin Cities team has developed a new tool to predict and customize the rate of DNA editing, paving the way for more personalized, efficient genetic and cell therapies for diseases such as diabetes and cancer.

   
Released: 15-Jul-2022 12:00 PM EDT
A New Treatment Approach for Cystic Fibrosis
Cold Spring Harbor Laboratory

Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells.

Newswise: Microfluidic-Based Soft Robotic Prosthetics Promise Relief for Diabetic Amputees
21-Jun-2022 11:00 AM EDT
Microfluidic-Based Soft Robotic Prosthetics Promise Relief for Diabetic Amputees
American Institute of Physics (AIP)

In Biomicrofluidics, scientists reveal their development of a new type of prosthetic using microfluidics-enabled soft robotics that promises to greatly reduce skin ulcerations and pain in patients who have had an amputation between the ankle and knee. They started with a recent device that uses pneumatic actuators and miniaturized the actuators by designing a microfluidic chip with 10 integrated pneumatic valves to control each actuator. The control box is small and light enough to be worn as part of the prosthesis.

   
Released: 27-Jun-2022 1:45 PM EDT
The latest expert commentary on SCOTUS decisions, including the overturn of Roe v. Wade
Newswise

The latest expert commentary and research on SCOTUS decisions, including the overturn of Roe v. Wade

       
Released: 24-Jun-2022 9:00 AM EDT
MD Anderson and Turning Point Therapeutics Announce Strategic Alliance to Advance Precision Cancer Therapies
University of Texas MD Anderson Cancer Center

MD Anderson and Turning Point Therapeutics announced a strategic research and development alliance to evaluate Turning Points investigational targeted therapies against ROS1, NTRK, MET and other cancer drivers.

Released: 22-Jun-2022 12:50 PM EDT
New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options
Texas Children's Hospital

A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum of heart defects that develop before birth and remain the leading cause of childhood death.

Released: 22-Jun-2022 10:30 AM EDT
Amid Surgical Mesh Concerns, Surgeons Are Asked: What Treatment Would You Choose for Yourself?
Wolters Kluwer Health: Lippincott

There is a long history of confusion and controversy regarding the use of polypropylene mesh materials for pelvic floor disorders in women, such as stress urinary incontinence (SUI) or pelvic organ prolapse (POP). So what option would specialist surgeons choose if they were to undergo these procedures themselves? That's the question asked in a survey study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.



close
2.07243